Gynecological Cancers Recommendations
To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
New to F1000? See this week’s top article below for a free preview of a Recommendation.
Gyn. Oncology, The Norwegian Radium Hospital, Oslo, Norway
Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, USA
Epidemiology and Cancer Registration Unit, Catalan Institute of Oncology, Barcelona, Spain
Department of Gynecology and Obstetrics, University of Brescia, Brescia, Italy
- » Cervical carcinomas
- » Gestational trophoblastic tumors
- » Melanoma and other rare gynecological tumors
- » Ovary, tube and peritoneum tumors: fallopian tube
- » Ovary, tube and peritoneum tumors: ovarian, germ and rare ovarian
- » Ovary, tube and peritoneum tumors: ovary epithelium
- » Ovary, tube and peritoneum tumors: peritoneum
- » Psychosocial and other sexual issues
- » Uterine tumors: endometrial
- » Uterine tumors: uterine sarcoma
- » Vaginal carcinomas
- » Vulvar carcinomas
Ovarian clear-cell and endometrioid carcinomas are closely associated with endometriosis, but they have different pathologic features and clinical behaviors. The early tumorigenesis of two types of ovarian cancer remains largely unknown. This paper discovers the...
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.Subscribe for $9.95/month
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.Recommend to your Librarian
If you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.Request an Institutional Trial
your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.